Fact of Medicine
Brand Name: Adakveo
Innovator Brand Name: Adakveo
API: Crizanlizumab
Packaging: 1 Vial (Per Box)
Strength: 100mg/10mL
Manufacturer Name: Novartis Pharma Corporation

Get Price


Crizanlizumab Medication

Adakveo (Crizanlizumab) specifically is a selectin blocker used in order to decrease the frequency of VOCs (Vaso-Occlusive Crises) in adults and pediatric patients aged sixteen years and older with SCD (Sickle Cell Disease).

Dosage: Administer crizanlizumab dose 5 mg per kg by intravenous infusion over a period of 30 minutes at 0, 2, and every 4 weeks thereafter. In case a dose is missed, administer Crizanlizumab promptly. In case Crizanlizumab injection is administered within a couple of weeks following the missed dose, dosing must be continued on behalf of the patient’s apt or original schedule. If Crizanlizumab injection is administered more than a couple of weeks following the missed dose, dosing should be continued every four weeks thereafter. Crizanlizumab may be given either with or without hydroxyurea.

Side Effects: The most commonly reported crizanlizumab side effects include:

  • Nausea
  • Arthralgia
  • Back pain
  • Pyrexia

Warnings and Precautions:

  • It is advised that crizanlizumab should be prepared and administered by an experienced healthcare practitioner.
  • Crizanlizumab-tmca is intended as a long-term therapy. Patients will be regularly monitored by their health care team for their condition and treatment plan.
  • Monitor patients with adakveo drug for signs/symptoms of infusion-related reactions including vomiting, fever, chills, nausea, fatigue, dizziness, pruritus, sweating, urticaria, shortness of breath or wheezing.
  • Inform your doctor that you are on adakveo before having any blood tests. Adakveo could interfere with a laboratory test in order to measure your platelet counts.
  • Before crizanlizumab use, remember to tell your doctor about all of your medical conditions, including if you’re pregnant or want to become pregnant. It is not known if this drug may harm your unborn baby.

More info

Storage: Adakveo (Crizanlizumab-tmca) should be stored and transported refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Neither shake nor freeze it. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the ADAKVEO at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the ADAKVEO Injections. Buying Procedure: In order to buy ADAKVEO, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusion: Crizanlizumab appears to be quite efficacious in reducing the frequency of VOCs in patients with Sickle Cell Disease. Treatment with crizanlizumab demonstrates promise as a preventative agent for Vaso-Occlusive Crises (VOCs), which may significantly affect the QoL in patients with Sickle Cell Disease.


What is Adakveo (crizanlizumab-tmca)? Adakveo is used:
  • in patients aged 16 years and older who have SCD (Sickle Cell Disease).
  • in order to help decrease how often certain episodes (crises) occur.
  • It is unspecified if adakveo is safe and effective in children aged under 16 years.
What does Adakveo contain as an active substance? The medication Adakveo specifically contains the active substance Crizanlizumab-tmca. Is Crizanlizumab an FDA approved drug? Yes, Crizanlizumab is an FDA approved drug. How much does adakveo cost? The adakveo price in India usually may vary depending on the wholesaler/pharmacy you visit and of course the brand you choose. What is the best price for Crizanlizumab? Please contact Toll-free: +91 1800 889 1064|+919310090915 for crizanlizumab price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements. Can I get Adakveo (Crizanlizumab) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Adakveo (Crizanlizumab), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.